|Year : 2016 | Volume
| Issue : 1 | Page : 1-9
Ultrathin Descemet's Stripping Automated Endothelial Keratoplasty Using the Double-pass Technique with the Microkeratome versus Standard Descemet's Stripping Automated Endothelial Keratoplasty
Ossama El Hadad1, Massimo Busin2, Tamer Massoud1, Silvana Madi2
1 Department of Ophthalmology, Alexandria University, Alexandria, Egypt
2 Department of Ophthalmology, Alexandria University, Alexandria, Egypt; Department of Ophthalmology, Villa Igea' Hospital, Forlì, Italy
|Date of Submission||21-Mar-2016|
|Date of Web Publication||18-Nov-2016|
Department of Ophthalmology, Villa Igea’ Hospital, Viale Gramsci 42, 47122 Forlì Italy
Source of Support: None, Conflict of Interest: None
Purpose The aim of the present study was to compare the results of Descemet's stripping automated endothelial keratoplasty (DSAEK) and ultrathin Descemet's stripping automated endothelial keratoplasty (UT-DSAEK) that were performed with a standardized technique at a single institution.
Design The present study was designed as a single-center, prospective, randomized nonblinded study.
Participants and methods Sixty-one and 51 eyes underwent DSAEK and UT-DSAEK, respectively, for any endothelial disease at the ‘Villa Igea’ Center. Patients with pre-existing ocular comorbidity that impacted visual potential such as macular degeneration, amblyopia, advanced glaucoma, and other optic neuropathies were excluded from the study. Best-corrected visual acuity (BCVA) (in Snellen acuity chart) was obtained and specular microscopy of donor corneal tissue was performed before surgery. Postoperative complications, BCVA, and the percent of endothelial cell loss (ECL) recorded at 1, 3, 6 months, and 1 year were compared.
Main outcome measures Visual acuity improvement, ECL, intraoperative postoperative complications, iatrogenic primary graft failure, and rebubbling were the main outcome measures in this study.
Results Mean ± SD BCVA improved from 0.17 ± 0.13 and 0.19 ± 0.13 before surgery to 0.75 ± 0.18 and 0.88 ± 0.19 at 1 year after DSAEK and UT-DSAEK, respectively (P = 0.001). ECL was 33.88 ± 17.74% after DSAEK and 36.37 ± 13.10% after UT-DSAEK (P = 0.4080). There were no iatrogenic primary graft failures after the two procedures but there were two late endothelial failures after DSAEK. Rebubbling was performed for four of 51 eyes after UT-DSAEK and for none after DSAEK (P = 0.04).
Conclusion Compared with DSAEK, UT-DSAEK provided better visual recovery and comparable ECL. The UT-DSAEK group had a higher percentage of rebubbling procedures but less rejection and failure rate.
Keywords: DSAEK, endothelial, fuch's, keratoplasty, ultrathin DSAEK
|How to cite this article:|
El Hadad O, Busin M, Massoud T, Madi S. Ultrathin Descemet's Stripping Automated Endothelial Keratoplasty Using the Double-pass Technique with the Microkeratome versus Standard Descemet's Stripping Automated Endothelial Keratoplasty. Egypt J Cataract Refract Surg 2016;22:1-9
|How to cite this URL:|
El Hadad O, Busin M, Massoud T, Madi S. Ultrathin Descemet's Stripping Automated Endothelial Keratoplasty Using the Double-pass Technique with the Microkeratome versus Standard Descemet's Stripping Automated Endothelial Keratoplasty. Egypt J Cataract Refract Surg [serial online] 2016 [cited 2017 Oct 19];22:1-9. Available from: http://www.jcrs.eg.net/text.asp?2016/22/1/1/194367
| Introduction|| |
Penetrating keratoplasty (PK) was the only procedure available for decades for the therapy of patients with vision loss due to endothelial disease. This made the primary decision for the corneal transplant easy for the surgeon, with decisions of trephination size, suturing style, and other technique-specific decisions to be made secondarily. Over the past decade, however, the field of endothelial keratoplasty (EK) has evolved, making the process of deciding what to do for the specific patient more complicated. Volumes of data over the past 10 years have demonstrated that all the posterior lamellar techniques of endothelial replacement yield far superior results compared with PK  and .
In the last few years, EK has established itself as the gold standard for the treatment of endothelial failure of various origins . As early as 2007, 85% of the donor corneas provided by the Eye Bank Association of America for patients with endothelial dysfunction were used in the EK procedures (2007 Eye Banking Statistical Report, available from the Eye Bank Association of America at: http://www.restoresight.org) and EK amounted to about 40% of all cornea grafts performed since 2009 . Descemet's stripping automated endothelial keratoplasty (DSAEK) is by far the most popular technique to replace the diseased endothelium.
Contrasting evidence has linked postoperative vision to the thickness of DSAEK grafts ,,,,,. In 2011, Neff et al.  reported post-DSAEK visual results to be better than those of the post-descemet membrane endothelial keratoplasty (DMEK) ones in patients with grafts thinner than 131 μm, thus correlating the first-time postoperative vision to the morphologic characteristics of the DSAEK tissue transplanted.
We compared herein the results of a prospective study investigating the outcomes of DSAEK procedures employing donor tissue prepared with the microkeratome-assisted double pass technique [ultrathin Descemet's stripping automated endothelial keratoplasty (UT-DSAEK)] with conventional DSAEK, as published previously .
| Participants and methods|| |
The study included 112 eyes that were divided into two groups (DSAEK and UT-DSAEK). Sixty-one and 51 eyes underwent DSAEK and UT-DSAEK procedure, respectively. All were operated on by the same surgeon (M.B.) using the conventional DSAEK and microkeratome-assisted double-pass technique at ‘Villa Igea’ Private Hospitals (Forli, Italy) from January 2012 until December 2015, and were included in a prospective, randomized, nonblinded comparative study aimed at evaluating the outcomes of the two techniques.
Patients with endothelial dysfunction resulting from causes other than Fuch's corneal dystrophy were included but patients with prior ocular surgery other than cataract surgery were excluded to limit confounding variables. Failed PK and ocular comorbidity that may affect visual potential such as macular degeneration, amblyopia, advanced glaucoma, and other optic neuropathies were excluded.
The study followed the tenets of the 1964 Declaration of Helsinki and was approved by the local ethics committee; detailed informed consent was signed by all patients undergoing UT-DSAEK. Preoperatively, all patients underwent a complete ophthalmological examination, including the slit-lamp examination, uncorrected, and best spectacle-corrected visual acuity, manifest refraction, applanation tonometry, fundoscopy, and B-scan ultrasound (if required).
Descemet's stripping automated endothelial keratoplasty
The donor cornea was mounted on an artificial anterior chamber (AAC) of the ALTK System (Moria, Antony, France). One pass was done using a Carriazo-Barraquer microkeratome with a 300-μm head. Pressure in the system was standardized by raising the infusion bottle to a height of 120 cm above the level of the AAC and then by clamping the tube at 50 cm from the entrance to the AAC.
Ultrathin Descemet's stripping automated endothelial keratoplasty
The donor cornea was mounted on an AAC of the ALTK System (Moria). The central corneal thickness was measured using ultrasound pachymetry (Alcon, Fort Worth, Texas, USA). An initial debulking was carried out using a Carriazo-Barraquer microkeratome with a 300 μm head. A second microkeratome-assisted refinement dissection was carried out according to the thickness measured by ultrasound pachymetry according to the Busin nomogram [Table 1]. Pressure in the system was standardized by raising the infusion bottle to a height of 120 cm above the level of the AAC and then clamping the tube at 50 cm from the entrance to the AAC.
Surgery was performed using peribulbar anesthesia in all cases. The surgery was performed using the standard DSAEK technique previously describe d  with the following modifications in UT-DSAEK . The graft was inserted using the pull-through technique with the modified mini-Busin glide. The graft was allowed to unfold spontaneously under continuous irrigation from the anterior chamber maintainer.
For patients undergoing a triple procedure (UT-DSAEK and phacoemulsification with intraocular lens [IOL] implantation), phacoemulsification and IOL implantation were carried out before UT-DSAEK surgery. No viscoelastics were used throughout the procedure. Capsulorrhexis was performed using a bent needle mounted on a syringe filled with saline to maintain a closed system, whereas the IOL was implanted under continuous irrigation from an anterior chamber maintainer placed at the 12 O’clock position. Intracameral acetylcholine chloride was used to constrict the pupil before UT-DSAEK surgery.
After surgery, patients were instructed to lie supine for at least 2 h. All patients were examined about 3 h after the surgery at the slit-lamp and some air was removed if no aqueous had entered the anterior chamber from behind the iris through the peripheral inferior iridotomy.
Postoperatively, all patients were given topical tobramycin 0.3%, and dexamethasone 0.1%, and suspension combination therapy every 2 h for 2 weeks, and then every 3 h for 2 additional weeks. Treatment was switched to pure steroidal eye drops (dexamethasone 0.1%) four times daily for 1 month, three times daily for 1 month, twice daily for 1 month, and then finally daily, which was continued indefinitely unless the patient was phakic or steroid responder. All sutures were removed in all cases between 4 and 6 weeks from the surgery.
Each patient underwent a complete ophthalmological examination 1, 3, 6, and 12 months after undergoing the two procedures, including the slit-lamp examination, best-corrected visual acuity (BCVA), manifest refraction, and applanation tonometry. Baseline donor endothelial cell density was measured by the provider eye bank using specular microscopy. Postoperative endothelial cell density was measured using a noncontact specular microscopy (EM-3000; Tomey, Tennenlohe, Germany). In addition, 1 year postoperatively, graft thickness was measured in each patient centrally using the anterior segment optical coherence tomography (OCT) (Spectralis HRA+OCT; Heidelberg Engineering, Heidelberg, Germany). BCVA was measured using Snellen acuity.
Statistical analyses were performed using the SPSS software (version 20.0; SPSS Inc., Chicago, Illinois, USA). Statistical significance between preoperative and postoperative values was tested using the Student t-test. A value below 0.05 was considered statistically significant. Normal distribution of values was reported as mean ± SD. For normally distributed data, groups were compared using the Student t-test and χ2 analysis.
| Results|| |
Mean ± SD patient ages were 65.7 ± 13.5 and 70.7 ± 8.7 years for the DSAEK and UT-DSAEK groups, respectively (P = 0.085). Transplantation with concurrent cataract surgery (triple procedure) was performed in 31 (50.8%) eyes in the DSAEK group and 25 (49%) eyes in the UT-DSAEK group (P = 0.456). The remaining eyes were pseudophakic at the time of their initial evaluation. Indications of DSAEK and UT-DSAEK were Fuchs’ dystrophy, pseudophakic bullous keratopathy, posterior polymorphous dystrophy, herpetic endotheliitis, and failed DSAEK. The predominant preoperative indications for both groups were Fuchs’ dystrophy and pseudophakic bullous keratopathy. There was no statistical significance among the two groups ([Table 2]).
|Table 2 Indications of ultrathin Descemet's stripping automated endothelial keratoplasty and Descemet's stripping automated endothelial keratoplasty|
Click here to view
Mean ± SD BCVA improved from 0.17 ± 0.13 and 0.19 ± 0.13 before surgery to 0.75 ± 0.18 and 0.88 ± 0.19 at 1 year after DSAEK and UT-DSAEK, respectively. There was no significant difference in mean preoperative visual acuity. However, there was a significant difference in the mean postoperative visual acuity between DSAEK and UT-DSAEK eyes ([Table 3] and [Figure 1]).
|Table 3 Best-corrected visual acuity results after ultrathin Descemet's stripping automated endothelial keratoplasty and Descemet's stripping automated endothelial keratoplasty in all eyes without comorbidities|
Click here to view
|Figure 1 UCVA before surgery and at different follow up periods at the 2 study groups.|
Click here to view
At 1 year, in the DSAEK group, a total of 91.8% of eyes reached a BCVA of 0.5 or better, 60.7% of eyes reached a visual acuity of 0.8 or better, and 11.5% of eyes reached a visual acuity of 1.0 at 1 year after surgery. In the UT-DSAEK group, all eyes reached a BCVA of 0.5 or better, 78.4% of eyes reached a visual acuity of 0.8 or better, and 43.1% of eyes reached a visual acuity of 1.0 at 1 year after surgery ([Table 4] and [Figure 2]).
|Table 4 Best-corrected visual acuity results after ultrathin Descemet's stripping automated endothelial keratoplasty and Descemet's stripping automated endothelial keratoplasty in all eyes without comorbidities|
Click here to view
Endothelial cell loss
Mean ± SD endothelial cell loss percentage (ECL%) at 1 month after DSAEK and UT-DSAEK surgeries was 24.4 ± 11.2 and 27.6 ± 11.7%, respectively (P = 0.595). At 3 months, the mean ± SD ECL% after DSAEK and UT-DSAEK surgeries was 29.1 ± 15.0 and 31.1 ± 12.4%, respectively (P = 0.153). Mean ± SD ECL% at 6 month after DSAEK and UT-DSAEK surgeries was 31.9 ± 16.9 and 30.2 ± 13.6%, respectively (P = 0.653). At 1 year, the mean ± SD ECL% after DSAEK and UT-DSAEK surgeries was 33.9 ± 17.7 and 36.4 ± 13.1%, respectively (P = 0.408) ([Figure 3]).
Average postcut donor corneal thickness at 1 month after DSAEK and UT-DSAEK surgeries was 163.40 ± 44.13 and 89.25 ± 40.22 μm, respectively (P < 0.001). At 3 months, the average postcut donor corneal thickness after DSAEK and UT-DSAEK surgeries was 150.10 ± 37.28 and 78.41 ± 29.64 μm, respectively (P < 0.001). Average postcut donor corneal thickness at 6 month after DSAEK and UT-DSAEK surgeries was 152.68 ± 35.22 and 79.82 ± 29.52 μm, respectively (P < 0.001). At 1 year, the average postcut donor corneal thickness after DSAEK and UT-DSAEK surgeries was 143.25 ± 29.91 and 76.04 ± 30.28 μm, respectively (P < 0.001).
In the DSAEK group, at 1 year, 37 eyes had a central graft thickness (GT) above 130 μm (73.8%). Twenty-four (39.3%) eyes had a central GT below 130 μm, and one (1.6%) eye had a central GT below 100 μm. None of the grafts had GT below 80 μm. In the UT-DSAEK group, at 1 year, only two grafts had a central GT above 130 μm (3.9%). Forty-nine (96.1%) eyes had a central GT below 130 μm, 43 (84.3%) eyes below 100 μm, and 29 (59.6%) eyes below 80 μm.
Postoperative complications are summarized in [Table 5]. Rebubbling was carried out in four eyes with total detachment after UT-DSAEK (P = 0.04) and none after DSAEK. All detachments in the UT-DSAEK group resolved after one air injection and none of them failed.
|Table 5 Complications after ultrathin Descemet's stripping automated endothelial keratoplasty and Descemet's stripping automated endothelial keratoplasty|
Click here to view
There were two immunologic graft rejections for the 12 months in the UT-DSAEK group. Four eyes in the DSAEK group had an immunologic rejection episode in this period. All rejections in the two groups resolved completely with topical steroid therapy.
There were no cases of iatrogenic primary graft failure in the two groups. There were two late endothelial failures in the DSAEK group.
Two perforations occurred during donor preparation in the UT-DSAEK group. It occurred while using the 50 μm head in the second pass.
| Discussion|| |
Many authors claim that the final visual acuity following DSAEK is suboptimal, with fewer eyes than expected achieving 20/20 vision, possibly because of the presence of a stromal interface ,,,,,. In comparison with most of the DSAEK series published to date, DMEK has shown a decisive improvement in terms of speed of visual recovery, percentage of patients achieving 20/20 vision, and rate of immunologic rejection ,,. However, ease of graft preparation, manipulation, delivery and attachment, and feasibility of the procedure for eyes with complicated anatomy or poor intraoperative visualization limit the use of DMEK even in the hands of an experienced corneal surgeon.
Ideally, every surgeon would like to use grafts that can be manipulated as easily as DSAEK ones are, but produce the same visual results of DMEK grafts.
No standardized method to obtain DSAEK grafts of a required thickness was available. All the reports published to date on this topic analyzed retrospectively the correlation between graft thickness and postoperative visual performance, thus strongly affecting its significance. We recently developed a technique aimed at reproducibly preparing what was named UT-DSAEK grafts – that is, DSAEK grafts thinner than 131 μm, with a double microkeratome pass – and could therefore undertake a prospective evaluation of the influence of DSAEK graft thickness on visual outcomes .
In our prospective study, it was found that visual recovery is significantly faster and better in the UT-DSAEK group as can be seen in [Table 3] and [Table 4] and [Figure 1] and [Figure 2]. This coincides with the results published in a study by Busin et al. , in which they found that the visual results after UT-DSAEK almost overlap with DMEK throughout the entire follow-up period, whereas the results of conventional DSAEK remains at a lower level.
Various studies have reported mean BCVA of 20/40 at 3–6 months postoperatively, with the average ranging from 0.6 to 0.3 and the follow-up ranging from 3 to 30 months . Our results for the two groups (UT-DSAEK and DSAEK) showed better visual acuity than those in other studies, as we excluded visual comorbidities (e.g. retinal disease and glaucoma) from our visual analysis.
In this study, a reliable double-pass microkeratome-assisted dissection of donor tissue was obtained, creating consistently thin and symmetric grafts with minimal loss of tissue, with a mean ± SD thickness of 76.04 ± 30.28 μm.
Using the past technique, the only major limitation of microkeratome dissection was its poor accuracy in determining the final thickness of the dissected tissue. As the head size increases, there seems to be a greater variation in the resulting thicknesses cut. Therefore, using a cutting head of 450 or 500 μm would increase the risk of perforation of the residual stromal bed with poor reproducibility of results. Thus, to prevent perforation, the tissue for DSAEK is cut with heads 300 or 350 μm, often resulting in a donor button with a significant amount of residual deep stroma ,,,.
In our technique, to standardize microkeratome dissection of donor tissue, the pressure was set in the ALTK System at a fixed level by clamping the infusion tube at 50 cm from its entrance to the artificial chamber system. The ‘closed system’ condition obtained in this way guarantees homogeneous pressure in the system throughout the dissection and is easily reproducible. In addition, to minimize the risk for perforation, we used a double-cut type of preparation . If a single cut is performed using microkeratome heads with slits wider than 350 μm, the actual thickness of the excised lamellae can vary from the intended thickness of 100 μm or more .
Busin et al. showed that after bringing down the thickness of the donor tissue to less than 200 μm with the first debulking dissection, a second cut can be made safely using microkeratome heads with narrow slits (e.g. 130 μm), which allow for more limited variations in the thickness of the excised lamella. They also demonstrated in his study that the risk for perforation increases if both dissections are started at the same site, probably because the microkeratome blade reaches the deepest point in the tissue at the beginning of the cut. Therefore, they recommended rotating the dovetail by 180° and therefore starting the second dissection from the other side. We carried out the intended procedure successfully in all the tested corneas, independently of the technique used. This was also demonstrated in another study , in which, according to the precut corneal thickness, the researchers chose the heads used in the first and second cut but they used the anterior segment OCT in measuring corneal thickness in both cuts .
Tissue loss due to central perforation during preparation of UT-DSAEK grafts (two cases; 2.1%) occurred less often than during the preparation of DMEK grafts (3.9%), always with the use of a 50 μm microkeratome head to perform the second cut in a residual bed of central thickness below 190 μm. Inaccuracy in the evaluation of the residual bed thickness by means of ultrasonic pachymetry could explain this complication, particularly if inadvertently measurements were taken paracentrally. The use of an anterior segment OCT to evaluate the residual bed after the debulking cut could prove essential in avoiding even this low percentage of central perforations. This was confirmed in a study by Busin et al. and , in which he recommended not using the 50 μm head for the same reason.
Mean ± SD ECL% at 1 year was 33.88 ± 17.74 and 36.37 ± 13.10% in the DSAEK and UT-DSAEK groups, respectively. There was no significant difference in the ECL between the UT-DSAEK and DSAEK groups in our study ([Figure 3]). This proves that the double-pass technique did not lead to any further increase in the ECL. We found the ECL to be greater at 3 months, which stabilized afterwards.
Six-month ECL for DSAEK ranged from 13 to 54% ,,,,,, and ECL at 1 year ranged from 15.6 to 61% ,, (Table 32). This further confirms our findings that most of the ECL in DSAEK occurs more in the first 3 months.
This is also consistent with an earlier finding that cell loss in DSAEK patients plateaus more quickly than in those who undergo PK for similar moderate risk indications in a 1-year study in which the endothelial cell density images were analyzed by a central microscopy reading center .
Higher ECL after EK surgery can be attributed to the technically challenging donor preparation and insertion techniques, especially in the early learning phase . Most reports of cell loss in DSAEK involved early cases where techniques were still relatively primitive, and as techniques have improved, cell loss has decreased . That was one of the reasons that the ECL in both groups was considered lower than what had been reported in other studies, as the surgeon in this study had passed the learning curve in DSAEK surgery and UT-DSAEK technique did not differ much from the conventional DSAEK surgery.
In this study, the Busin glide was used for the insertion of the DSAEK and UT-DSAEK graft. Most important advantage of this approach is that the donor endothelium remains protected during the entire procedure. Possibly damaging maneuvers such as folding the graft, squeezing the tissue through the surgical wound with a forceps, or touching the endothelial surface with various instruments while trying to unfold the graft are eliminated. In addition, the persistence of a viscoelastic coating on the internal surface of the graft protects the endothelium if the edges curl over each other while the tissue roll flattens and is dragged through the incision  and .
Although postoperative graft dislocation was higher after UT-DSAEK (four eyes; 7.8%) and none after DSAEK, it was still much less than that reported after DMEK by Price et al. (63%), Guerra et al. (60%), and Laaser et al. (92%). UT-DSAEK grafts, not different from DSAEK ones, have a shape of their own. Partial UT-DSAEK or conventional DSAEK graft detachments, therefore, do not need rebubbling because they usually zip down on their own over time ,,.
Donor dislocation rates reported after DSAEK vary from as low as 0% to as high as 82% (Table 32) ,,,,,. To attach the graft, it should be in mechanical contact with the recipient cornea for a long period of time after surgery with no fluid in the interface .
It was found that leaving full air tamponade and tight wound closure for 2 h postoperatively is sufficient for graft attachment as it squeezes the fluid out of the interface, which is also suggested by another study where high intraocular pressure was needed to achieve graft attachment . In this study, there were no cases with pupillary block syndrome after both UT-DSAEK or DSAEK because a peripheral inferior iridotomy was always performed and air was removed after 2 h to leave a level above the inferior iridotomy.
In our study, we did not repeat any procedure because of poor BCVA in either groups, which was similar to the findings of other studies ,,. Yet, the numbers in our study are small and need further investigation.
In our study, none of the cases experienced primary graft failures after UT-DSAEK and DSAEK procedures, maybe because we excluded all eyes with comorbidities – for example, previous PK failure, glaucoma surgery, and aphakic eyes, which make the procedure more difficult, and due to the surgeon experience in the procedure before, which is an important factor leading to graft failure.
Primary graft failure is considered the third most common DSAEK complication in the reviewed literature, with a range of 0–29% and an average primary graft failure rate of 5% among all published studies . In comparison, Mead et al. found a primary failure rate of 2.7% in 778 PK eyes, whereas Wilhelmus et al. found a 2% primary graft failure rate in a review of the Adverse Reaction Registry of the Eye Bank Association of America, which included 7240 donor corneas undergoing PK. In their study, de Freitas et al. found a 17% primary graft failure rate in 213 eyes that underwent PK, performed by cornea experts, likely reflecting the increased endothelial trauma from surgeon inexperience with technique and tissue handling. Terry , Chen et al. proposed that the same scenario may occur in DSAEK and cautioned that poor surgical technique, excessive tissue handling, and the use of specific surgical steps that are inherently more traumatic are all associated with a higher risk for primary graft failure.
Although our study had limited number of participants and a relatively shorter follow-up, the graft survival in our study after DSAEK and UT-DSAEK at 1 year was 96.7 and 100%, respectively, which is close to what has been reported in the previous studies ,,,,,,,,,,. There was no statistical significance between the two groups (P = 0.5).
One-year graft survival rates for DSEK have ranged from 55 to 100%. After exclusion of the reports of surgeons during their early learning curve, the range of clear DSAEK grafts at 1 year is 94–100% ,,,,,,,,,,. Busin et al. reported a graft survival probability of UT-DSAEK at 1, 3, 6, 12, and 24 months as 98.6, 98.2, 97.8, 97.8, and 96.2%, respectively. We could not confirm these findings in our series, probably because of the small number of failed grafts, as well as the relatively short follow-up time.
Rejection rates after DSAEK was double to that after UT-DSAEK at 1 year of follow-up, but this was not statistically significant (P = 0.687) due to limited number of the study and limited number of follow-up. Similarly, Busin et al. reported a Kaplan–Meier cumulative probability for a rejection episode after UT-DSAEK at 3, 6, 12, and 24 months of 0, 0.4, 2.4, and 3.3, respectively. Anshu et al. have reported the Kaplan–Meier cumulative probability of a rejection episode at 1 and 2 years to be 1 and 1%, respectively, for DMEK; 8 and 12%, respectively, for DSAEK; and 14 and 18%, respectively, for PK. In a different study, Guerra et al. found the rejection rate to be 5.7% 1 year after DMEK. In another series, evaluating rejection after DSAEK, Li et al. found that the estimated probability of a rejection episode was 6% by 1 year and 10% by 2 years after DSAEK. From these findings, it is clear that immunologic rejection can complicate the postoperative course of UT-DSAEK in a much lower percentage of cases than that of DSAEK and slightly higher than DMEK.
A limitation of this study was that most of the eyes in this study were treated for Fuchs’ dystrophy; additional studies on larger cohorts with bullous keratopathy and with pre-existing glaucoma would be valuable. A larger number of participants and a longer follow-up would be helpful to compare between the two groups to confirm our results.
In conclusion, our series indicated that UT-DSAEK as a procedure shares the improved visual outcome and lower immunologic rejection rate of DMEK over DSAEK, while minimizing all types of postoperative complications. In addition, similar to DSAEK and unlike DMEK, UT-DSAEK can be performed in all types of eyes, even in those with complicated anatomy (i.e. free communication between anterior chamber and vitreous cavity as in aphakia, presence of anterior chamber IOLs, etc.) or poor anterior chamber visualization. Finally, UT-DSAEK grafts can be routinely dissected even by relatively inexperienced eye bank technicians, and can be easily evaluated, thus reducing tissue waste and further improving the quality of the tissue to be transplanted.
Financial support and sponsorship
Conflicts of interest
Massimo Busin receives travel expenses reimbursement and royalties from Moria (Antony, France). For the remaining authors there are no conflicts of interest.
| References|| |
Anshu A, Price MO, Tan DTH, Price FWJr. Endothelial keratoplasty: a revolution in evolution. Surv Ophthalmol 2012; 57:236–252.
Lee WB, Jacobs DS, Musch DC, Kaufman SC, Reinhart WJ, Shtein RM. Descemet's stripping endothelial keratoplasty: safety and outcomes: a report by the American Academy of Ophthalmology. Ophthalmology 2009; 116:1818–1830.
Neff KD, Biber JM, Holland EJ. Comparison of central corneal graft thickness to visual acuity outcomes in endothelial keratoplasty. Cornea 2011; 30:388–391.
Dickman MM, Cheng YY, Berendschot TT, van den Biggelaar FJ, Nuijts RM. Effects of graft thickness and asymmetry on visual gain and aberrations after Descemet stripping automated endothelial keratoplasty. JAMA Ophthalmol 2013; 131:737–744.
Terry MA, Straiko MD, Goshe JM, Li JY, Davis-Boozer D. Descemet's stripping automated endothelial keratoplasty: the tenuous relationship between donor thickness and postoperative vision. Ophthalmology 2012; 119:1988–1996.
Woodward MA, Raoof-Daneshvar D, Mian S, Shtein RM. Relationship of visual acuity and lamellar thickness in Descemet stripping automated endothelial keratoplasty. Cornea 2013; 32:e69–e73.
Van Cleynenbreugel H, Remeijer L, Hillenaar T. Descemet stripping automated endothelial keratoplasty: effect of intraoperative lenticule thickness on visual outcome and endothelial cell density. Cornea 2011; 30:1195–1200.
Ahmed KA, McLaren JW, Baratz KH, Maguire LJ, Kittleson KM, Patel SV. Host and graft thickness after Descemet stripping endothelial keratoplasty for Fuchs endothelial dystrophy. Am J Ophthalmol 2010; 150:490–7e2.
Busin M, Madi S, Santorum P, Scorcia V, Beltz J. Ultrathin Descemet's stripping automated endothelial keratoplasty with the microkeratome double-pass technique: two-year outcomes. Ophthalmology 2013; 120:1186–1194.
Busin M, Bhatt PR, Scorcia V. A modified technique for Descemet membrane stripping automated endothelial keratoplasty to minimize endothelial cell loss. Arch Ophthalmol 2008; 126:1133–1137.
Anshu A, Price MO, Price FWJr. Risk of corneal transplant rejection significantly reduced with Descemet's membrane endothelial keratoplasty. Ophthalmology 2012; 119:536–540.
Anshu A, Price MO, Price FWJr. Descemet membrane endothelial keratoplasty and hybrid techniques for managing failed penetrating grafts. Cornea 2013; 32:1–4.
Guerra FP, Anshu A, Price MO, Giebel AW, Price FW. Descemet's membrane endothelial keratoplasty: prospective study of 1-year visual outcomes, graft survival, and endothelial cell loss. Ophthalmology 2011; 118:2368–2373.
Bahar I, Kaiserman I, Sansanayudh W, Levinger E, Rootman DS. Busin guide vs forceps for the insertion of the donor lenticule in Descemet stripping automated endothelial keratoplasty. Am J Ophthalmol 2009; 147:220–260.
Bahar I, Kaiserman I, McAllum P, Slomovic A, Rootman D. Comparison of posterior lamellar keratoplasty techniques to penetrating keratoplasty. Ophthalmology 2008; 115:1525–1533.
Covert DJ, Koenig SB. Descemet stripping and automated endothelial keratoplasty (DSAEK) in eyes with failed penetrating keratoplasty. Cornea 2007; 26:692–696.
Covert DJ, Koenig SB. New triple procedure: Descemet's stripping and automated endothelial keratoplasty combined with phacoemulsification and intraocular lens implantation. Ophthalmology 2007; 114:1272–1277.
Gorovoy MS. Descemet-stripping automated endothelial keratoplasty. Cornea 2006; 25:886–889.
Gupta PK, Bordelon A, Vroman DT, Afshari NA, Kim T. Early outcomes of Descemet stripping automated endothelial keratoplasty in pseudophakic eyes with anterior chamber intraocular lenses. Am J Ophthalmol 2011; 151:24–8e1.
Koenig SB, Covert DJ. Early results of small-incision Descemet's stripping and automated endothelial keratoplasty. Ophthalmology 2007; 114:221–226.
Koenig SB, Covert DJ, Dupps WJJr, Meisler DM. Visual acuity, refractive error, and endothelial cell density six months after Descemet stripping and automated endothelial keratoplasty (DSAEK). Cornea 2007; 26:670–674.
Mehta JS, Por YM, Poh R, Beuerman RW, Tan D. Comparison of donor insertion techniques for Descemet stripping automated endothelial keratoplasty. Arch Ophthalmol 2008; 126:1383–1388.
Nottage JM, Nirankari VS. Endothelial keratoplasty without Descemet's stripping in eyes with previous penetrating corneal transplants. Br J Ophthalmol 2012; 96:24–27.
Wylegala E, Tarnawska D. Management of pseudophakic bullous keratopathy by combined Descemet-stripping endothelial keratoplasty and intraocular lens exchange. J Cataract Refract Surg 2008; 34:1708–1714.
Busin M, Albe E. Does thickness matter: ultrathin Descemet stripping automated endothelial keratoplasty. Curr Opin Ophthalmol 2014; 25:312–318.
Sikder S, Nordgren RN, Neravetla SR, Moshirfar M. Ultra-thin donor tissue preparation for endothelial keratoplasty with a double-pass microkeratome. Am J Ophthalmol 2011; 152:202–8e2.
Terry MA, Shamie N, Chen ES, Phillips PM, Hoar KL, Friend DJ. Precut tissue for Descemet's stripping automated endothelial keratoplasty: vision, astigmatism, and endothelial survival. Ophthalmology 2009; 116:248–256.
Chen ES, Phillips PM, Terry MA, Shamie N, Friend DJ. Endothelial cell damage in Descemet stripping automated endothelial keratoplasty with the underfold technique: 6- and 12-month results. Cornea 2010; 29:1022–1024.
Foster JB, Vasan R, Walter KA. Three-millimeter incision Descemet stripping endothelial keratoplasty using sodium hyaluronate (healon): a survey of 105 eyes. Cornea 2011; 30:150–153.
Khor WB, Mehta JS, Tan DT. Descemet stripping automated endothelial keratoplasty with a graft insertion device: surgical technique and early clinical results. Am J Ophthalmol 2011; 151:223–232.e2.
Price MO, Gorovoy M, Price FWJr, Benetz BA, Menegay HJ, Lass JH. Descemet's stripping automated endothelial keratoplasty: three-year graft and endothelial cell survival compared with penetrating keratoplasty. Ophthalmology 2013; 120:246–251.
Terry MA, Shamie N, Chen ES, Hoar KL, Friend DJ. Endothelial keratoplasty a simplified technique to minimize graft dislocation, iatrogenic graft failure, and pupillary block. Ophthalmology 2008; 115:1179–1186.
Price MO, Gorovoy M, Benetz BA, Price FWJr, Menegay HJ, Debanne SM et al.
Descemet's stripping automated endothelial keratoplasty outcomes compared with penetrating keratoplasty from the Cornea Donor Study. Ophthalmology 2010; 117:438–444.
Price MO, Giebel AW, Fairchild KM, Price FWJr. Descemet's membrane endothelial keratoplasty: prospective multicenter study of visual and refractive outcomes and endothelial survival. Ophthalmology 2009; 116:2361–2368.
Laaser K, Bachmann BO, Horn FK, Schlotzer-Schrehardt U, Cursiefen C, Kruse FE. Donor tissue culture conditions and outcome after Descemet membrane endothelial keratoplasty. Am J Ophthalmol 2011; 151:1007–1018.e2.
Clements JL, Bouchard CS, Lee WB, Dunn SP, Mannis MJ, Reidy JJ et al.
Retrospective review of graft dislocation rate associated with Descemet stripping automated endothelial keratoplasty after primary failed penetrating keratoplasty. Cornea 2011; 30:414–418.
Vaddavalli PK, Diakonis VF, Canto AP, Kankariya VP, Pappuru RR, Ruggeri M et al.
Factors affecting DSAEK graft lenticle adhesion: an in vitro experimental study. Cornea 2014; 33:551–554.
Mead MD, Hyman L, Grimson R, Schein OD. Primary graft failure: a case control investigation of a purported cluster. Cornea 1994; 13:310–316.
Wilhelmus KR, Stulting RD, Sugar J, Khan MM. Primary corneal graft failure. A national reporting system. Medical Advisory Board of the Eye Bank Association of America. Arch Ophthalmol 1995; 113:1497–1502.
de Freitas AM, Melo BC, Mendonca CN, Machado RP, Rocha FJ. Causes and risk factors for graft failure in surgeries performed by physicians in fellowship training. Cornea 2006; 25:251–256.
Terry MA. Endothelial keratoplasty: history, current state, and future directions. Cornea 2006; 25:873–878.
Chen ES, Terry MA, Shamie N, Hoar KL, Friend DJ. Precut tissue in Descemet's stripping automated endothelial keratoplasty donor characteristics and early postoperative complications. Ophthalmology 2008; 115:497–502.
Price FWJr, Price MO. Descemet's stripping with endothelial keratoplasty in 200 eyes: early challenges and techniques to enhance donor adherence. J Cataract Refract Surg 2006; 32:411–418.
Price MO, Price FWJr. Endothelial cell loss after Descemet stripping with endothelial keratoplasty influencing factors and 2-year trend. Ophthalmology 2008; 115:857–865.
Sarnicola V, Toro P. Descemet-stripping automated endothelial keratoplasty by using suture for donor insertion. Cornea 2008; 27:825–829.
Terry MA. The evolution of lamellar grafting techniques over twenty-five years. Cornea 2000; 19:611–616.
Anshu A, Price MO, Tan DTH, Price FWJr. Endothelial keratoplasty: a revolution in evolution. Surv Ophthalmol 2012; 57:236–252.
Li JY, Terry MA, Goshe J, Shamie N, Davis-Boozer D. Graft rejection after Descemet's stripping automated endothelial keratoplasty: graft survival and endothelial cell loss. Ophthalmology 2012; 119:90–94.
[Figure 1], [Figure 2], [Figure 3]
[Table 1], [Table 2], [Table 3], [Table 4], [Table 5]